BillionToOne, Inc. Class A Common Stock (BLLN)

Price$97.19

Value ScoreF

Growth ScoreF

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-33.27%

Price vs S&P 500 (4W)4.56%

VGM Score30.72

Market Capitalization$4.47B

P/E Ratio (Annual)599.72x

All Metrics

P/CF (Annual)181.76x

Book Value / Share (Quarterly)$11.00

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$0.58

Price vs S&P 500 (YTD)10.60%

Gross Margin (TTM)69.54%

Net Profit Margin (TTM)6.15%

EPS (TTM)$0.52

10-Day Avg Trading Volume0.77M

EPS Excl Extra (TTM)$0.52

EPS (Annual)$0.35

ROI (Annual)1.36%

Gross Margin (Annual)68.32%

Cash / Share (Quarterly)$11.69

P/E Basic Excl Extra (TTM)175.83x

Revenue Growth QoQ (YoY)-37.05%

P/E Normalized (Annual)599.72x

ROA (Last FY)1.18%

EBITD / Share (TTM)$0.93

Operating Margin (TTM)8.19%

Cash Flow / Share (Annual)$0.34

P/B Ratio8.84x

P/B Ratio (Quarterly)7.18x

Net Income / Employee (Annual)$10,500

Net Interest Coverage (TTM)10.09x

ROA (TTM)5.15%

EPS Incl Extra (Annual)$0.35

Current Ratio (Annual)11.69x

Quick Ratio (Quarterly)10.47x

3-Month Avg Trading Volume0.46M

EV / Free Cash Flow (Annual)257.29x

P/E Incl Extra (TTM)175.83x

Revenue / Employee (TTM)$579,900

P/S Ratio (Annual)14.65x

Asset Turnover (Annual)0.48x

52-Week High$138.70

EPS Excl Extra (Annual)$0.35

26-Week Price Return-25.34%

Quick Ratio (Annual)11.21x

13-Week Price Return34.67%

Total Debt / Equity (Annual)0.14x

Current Ratio (Quarterly)10.92x

Enterprise Value$4.03B

Asset Turnover (TTM)0.84x

Revenue / Employee (Annual)$427,900

Pretax Margin (Annual)2.54%

Cash / Share (Annual)$10.83

3-Month Return Std Dev91.93%

Net Income / Employee (TTM)$35,700

ROE (Last FY)1.55%

EPS Basic Excl Extra (Annual)$0.35

EV / Free Cash Flow (TTM)151.41x

Total Debt / Equity (Quarterly)0.20x

EPS Incl Extra (TTM)$0.52

ROI (TTM)6.31%

P/S Ratio (TTM)10.81x

Revenue / Share (Annual)$14.37

Forward P/E98.73x

P/E Ratio (TTM)175.83x

Year-to-Date Return18.76%

5-Day Price Return6.66%

EPS Normalized (Annual)$0.35

Net Profit Margin (Annual)2.44%

Month-to-Date Return-1.82%

EBITD / Share (Annual)$1.08

Operating Margin (Annual)5.25%

LT Debt / Equity (Annual)0.12x

P/CF (TTM)111.69x

P/E Excl Extra (TTM)175.83x

LT Debt / Equity (Quarterly)0.18x

EPS Basic Excl Extra (TTM)$0.52

P/B Ratio (Annual)7.80x

Pretax Margin (TTM)6.35%

Book Value / Share (Annual)$10.48

Price vs S&P 500 (13W)26.41%

Beta1.37x

P/FCF (Annual)285.22x

Revenue / Share (TTM)$7.80

ROE (TTM)7.62%

52-Week Low$61.96

vGradeF

gGradeF

mGradeB

vgmGradeD

Show chart for

Earnings Surprise History

Q1 260.34est. 0.05

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.21

About

BillionToOne Inc develops precision diagnostic tests using its proprietary Quantitative Counting Templates technology to enable ultrasensitive DNA analysis. The company offers non-invasive prenatal screening and cancer monitoring solutions designed to provide greater accuracy and cost-effectiveness than traditional genetic testing. BillionToOne serves two large markets—prenatal screening and oncology—where demand for improved diagnostics continues to grow.